Prelude Therapeutics cut the ribbon on their new 100,000 square foot headquarters building at the Chestnut Run Innovation and Science Park (CRISP) on Friday, February 9, 2024. The oncology company was born from Incyte Corporation in 2016, and as it grew moved from the STAR Campus, to the Experiment Station to CRISP.